Does severity of low-dose, double-blind, placebo-controlled food challenges reflect severity of allergic reactions to peanut in the community
Does severity of low-dose, double-blind, placebo-controlled food challenges reflect severity of allergic reactions to peanut in the community
Background: The severity of allergic reactions to food appears to be affected by many interacting factors. It is uncertain whether challenge-based reactions reflect the severity of past reactions or can predict future risk.
Objective: To explore the relationship of a subject's clinical history of past reactions to the severity of reaction elicited by a low-dose, double-blind, placebo-controlled food challenge (DBPCFC) with peanut.
Method: Cross-sectional questionnaire assessment of community-based allergic reactions and low-dose DBPCFC in self-selected peanut-allergic subjects. Reaction severity was assessed using a novel scoring system, taking account of the dose of allergen ingested.
Results: Forty subjects (15 males, 23 children, 23 asthmatics by history) were studied. Only the most recent community reaction predicted the severity of reaction in the DBPCFC, but even this association was weak (r=0.37, P=0.03). Peanut-specific IgE (PsIgE) and skin prick test (SPT) weal size were not associated with community score but PsIgE level correlated well with the challenge score (r=0.6, P=0.001). Asthma did not affect the eliciting dose or challenge score directly but the association of PsIgE and challenge score was stronger in those without asthma (r=0.72, P=0.001) than in those with asthma (r=0.48, P=0.02).
Conclusions: The scoring system developed appears to improve the sensitivity of assessment of reactions induced by DBPCFC. This is the first prospective study showing an association between PsIgE levels and clinical reactivity in DBPCFC, an effect that is more pronounced in non-asthmatics. This finding has important implications for the clinical care of subjects with food allergy. There is a poor correlation between the severity of reported reactions in the community and the severity of reaction elicited during low-dose DBPCFC with peanut.
1227-1233
Hourihane, J.O.
01ba1495-72e1-4522-b627-60a7d31aae20
Grimshaw, K.E.C.
766b6cf0-347a-447d-aeab-f07366f8ce28
Lewis, S.A.
fb9dc5ac-21d9-4dfe-b917-fc87116170e2
Briggs, R.A.
e38a0297-4c5a-4933-bd3a-0048e72b8f74
Trewin, J.B.
2c84d832-8f02-4914-be58-51a1d2848f17
King, R.M.
aad14b24-ad90-4efc-a91c-91ce27ab6c8a
Kilburn, S.A.
53dc2cb1-b1a6-4a0a-a6bf-9d8acddb79b6
Warner, J.O.
c232f1e5-62eb-46e6-8b0c-4836b45b36a5
2005
Hourihane, J.O.
01ba1495-72e1-4522-b627-60a7d31aae20
Grimshaw, K.E.C.
766b6cf0-347a-447d-aeab-f07366f8ce28
Lewis, S.A.
fb9dc5ac-21d9-4dfe-b917-fc87116170e2
Briggs, R.A.
e38a0297-4c5a-4933-bd3a-0048e72b8f74
Trewin, J.B.
2c84d832-8f02-4914-be58-51a1d2848f17
King, R.M.
aad14b24-ad90-4efc-a91c-91ce27ab6c8a
Kilburn, S.A.
53dc2cb1-b1a6-4a0a-a6bf-9d8acddb79b6
Warner, J.O.
c232f1e5-62eb-46e6-8b0c-4836b45b36a5
Hourihane, J.O., Grimshaw, K.E.C., Lewis, S.A., Briggs, R.A., Trewin, J.B., King, R.M., Kilburn, S.A. and Warner, J.O.
(2005)
Does severity of low-dose, double-blind, placebo-controlled food challenges reflect severity of allergic reactions to peanut in the community.
Clinical & Experimental Allergy, 35 (9), .
(doi:10.1111/j.1365-2222.2005.02312.x).
Abstract
Background: The severity of allergic reactions to food appears to be affected by many interacting factors. It is uncertain whether challenge-based reactions reflect the severity of past reactions or can predict future risk.
Objective: To explore the relationship of a subject's clinical history of past reactions to the severity of reaction elicited by a low-dose, double-blind, placebo-controlled food challenge (DBPCFC) with peanut.
Method: Cross-sectional questionnaire assessment of community-based allergic reactions and low-dose DBPCFC in self-selected peanut-allergic subjects. Reaction severity was assessed using a novel scoring system, taking account of the dose of allergen ingested.
Results: Forty subjects (15 males, 23 children, 23 asthmatics by history) were studied. Only the most recent community reaction predicted the severity of reaction in the DBPCFC, but even this association was weak (r=0.37, P=0.03). Peanut-specific IgE (PsIgE) and skin prick test (SPT) weal size were not associated with community score but PsIgE level correlated well with the challenge score (r=0.6, P=0.001). Asthma did not affect the eliciting dose or challenge score directly but the association of PsIgE and challenge score was stronger in those without asthma (r=0.72, P=0.001) than in those with asthma (r=0.48, P=0.02).
Conclusions: The scoring system developed appears to improve the sensitivity of assessment of reactions induced by DBPCFC. This is the first prospective study showing an association between PsIgE levels and clinical reactivity in DBPCFC, an effect that is more pronounced in non-asthmatics. This finding has important implications for the clinical care of subjects with food allergy. There is a poor correlation between the severity of reported reactions in the community and the severity of reaction elicited during low-dose DBPCFC with peanut.
This record has no associated files available for download.
More information
Published date: 2005
Identifiers
Local EPrints ID: 27151
URI: http://eprints.soton.ac.uk/id/eprint/27151
ISSN: 0954-7894
PURE UUID: 26c3c37a-c197-4032-bb30-19ca65636e9f
Catalogue record
Date deposited: 26 Apr 2006
Last modified: 15 Mar 2024 07:16
Export record
Altmetrics
Contributors
Author:
J.O. Hourihane
Author:
S.A. Lewis
Author:
R.A. Briggs
Author:
J.B. Trewin
Author:
R.M. King
Author:
S.A. Kilburn
Author:
J.O. Warner
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics